Exchange: NASDAQ·Updated 04:00 AM EDT
GELS logo

GELS Gelteq Ltd.

$0.4801
$0.00
(0.00%)
Pre-Market
Prev Close $0.4801
Mkt Cap$5.25M
Vol1.00

About GELS

Gelteq Ltd. operates as a biotechnology company. It focuses on the development and commercialization of white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care, and other products. The firm also offers edible gels. The company was founded by Nathan J. Givoni and Simon H. Szewach on October 15, 2018 and is headquartered in Melbourne, Australia.
45

Neutral Sentiment

How do you feel about GELS?

BullishBellee
$GELS Proprietary gel-based drug-delivery platform for human plus veterinary applications.[]~

Advertisement|Remove ads.